Serpaize, France

David Chognot

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Chognot: Innovator in Pharmaceutical Formulations

Introduction

David Chognot is a notable inventor based in Serpaize, France. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on the prolonged release of active principles. His innovative work has implications for therapeutic applications, showcasing his expertise in the pharmaceutical industry.

Latest Patents

David Chognot holds a patent for "Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications." This invention relates to novel pharmaceutical formulations based on aqueous colloidal suspensions designed for the prolonged release of one or more active principles. The formulations include an aqueous colloidal suspension of low viscosity based on micrometric particles of a water-soluble, biodegradable, amphiphilic polymer. These particles carry hydrophobic groups and ionizable hydrophilic groups that are at least partially ionized. They are capable of associating spontaneously and non-covalently with an active principle at pH=7.0 under isotonic conditions. The suspension also contains multivalent ions of opposite polarity to that of the hydrophilic groups, enhancing the effectiveness of the formulation.

Career Highlights

David Chognot is associated with Flamel Technologies, a company known for its innovative approaches in the pharmaceutical sector. His work has led to advancements in drug delivery systems, particularly in the area of sustained release formulations. With a focus on improving therapeutic outcomes, Chognot's contributions are vital to the ongoing development of effective pharmaceutical solutions.

Collaborations

Throughout his career, David has collaborated with notable colleagues such as Cécile Bonnet-Gonnet and Olivier Soula. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical field.

Conclusion

David Chognot's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His patent for prolonged release formulations highlights the importance of developing effective therapeutic applications. Through his contributions, Chognot continues to advance the field of pharmaceuticals, making a significant difference in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…